A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa
Clinical trial NCT00447993 · COMPLETED
Trial details
- NCT number
- NCT00447993
- Sponsor
- Neurotech Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-08
- Primary completion
- 2009-05-26
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.